MEDICURE INC (MPH.CA) Fundamental Analysis & Valuation

TSX-V:MPH • CA58469E4085

Current stock price

0.95 CAD
-0.02 (-2.06%)
Last:

This MPH.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. MPH.CA Profitability Analysis

1.1 Basic Checks

  • MPH had negative earnings in the past year.
  • MPH had a positive operating cash flow in the past year.
  • In the past 5 years MPH reported 4 times negative net income.
  • MPH had a positive operating cash flow in 4 of the past 5 years.
MPH.CA Yearly Net Income VS EBIT VS OCF VS FCFMPH.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

1.2 Ratios

  • MPH has a Return On Assets of -12.83%. This is amongst the best in the industry. MPH outperforms 82.61% of its industry peers.
  • MPH has a Return On Equity of -19.81%. This is amongst the best in the industry. MPH outperforms 82.61% of its industry peers.
Industry RankSector Rank
ROA -12.83%
ROE -19.81%
ROIC N/A
ROA(3y)-0.74%
ROA(5y)-4.98%
ROE(3y)-1.05%
ROE(5y)-8.57%
ROIC(3y)N/A
ROIC(5y)N/A
MPH.CA Yearly ROA, ROE, ROICMPH.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

1.3 Margins

  • Looking at the Gross Margin, with a value of 47.67%, MPH belongs to the top of the industry, outperforming 82.61% of the companies in the same industry.
  • MPH's Gross Margin has been stable in the last couple of years.
  • The Profit Margin and Operating Margin are not available for MPH so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 47.67%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.73%
GM growth 5Y-1.35%
MPH.CA Yearly Profit, Operating, Gross MarginsMPH.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100 150

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. MPH.CA Health Analysis

2.1 Basic Checks

  • MPH does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, MPH has about the same amount of shares outstanding.
  • MPH has less shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, MPH has a worse debt to assets ratio.
MPH.CA Yearly Shares OutstandingMPH.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
MPH.CA Yearly Total Debt VS Total AssetsMPH.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

  • Based on the Altman-Z score of -2.26, we must say that MPH is in the distress zone and has some risk of bankruptcy.
  • With a decent Altman-Z score value of -2.26, MPH is doing good in the industry, outperforming 60.87% of the companies in the same industry.
  • MPH has a debt to FCF ratio of 0.79. This is a very positive value and a sign of high solvency as it would only need 0.79 years to pay back of all of its debts.
  • MPH has a Debt to FCF ratio of 0.79. This is amongst the best in the industry. MPH outperforms 100.00% of its industry peers.
  • MPH has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
  • With an excellent Debt to Equity ratio value of 0.03, MPH belongs to the best of the industry, outperforming 82.61% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF 0.79
Altman-Z -2.26
ROIC/WACCN/A
WACC7.75%
MPH.CA Yearly LT Debt VS Equity VS FCFMPH.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M 80M

2.3 Liquidity

  • MPH has a Current Ratio of 1.44. This is a normal value and indicates that MPH is financially healthy and should not expect problems in meeting its short term obligations.
  • MPH has a better Current ratio (1.44) than 60.87% of its industry peers.
  • A Quick Ratio of 1.00 indicates that MPH should not have too much problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 1.00, MPH is in line with its industry, outperforming 56.52% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.44
Quick Ratio 1
MPH.CA Yearly Current Assets VS Current LiabilitesMPH.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. MPH.CA Growth Analysis

3.1 Past

  • MPH shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -68.69%.
  • MPH shows a strong growth in Revenue. In the last year, the Revenue has grown by 24.30%.
  • MPH shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.66% yearly.
EPS 1Y (TTM)-68.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-279.68%
Revenue 1Y (TTM)24.3%
Revenue growth 3Y0.25%
Revenue growth 5Y1.66%
Sales Q2Q%56.6%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MPH.CA Yearly Revenue VS EstimatesMPH.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
MPH.CA Yearly EPS VS EstimatesMPH.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 0 1 -1 2

More info and screens

Find the best growth stocksShow best growing peers

2

4. MPH.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for MPH. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MPH.CA Price Earnings VS Forward Price EarningsMPH.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

  • Based on the Price/Free Cash Flow ratio, MPH is valued cheaply inside the industry as 95.65% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 7.82
EV/EBITDA N/A
MPH.CA Per share dataMPH.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2 2.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. MPH.CA Dividend Analysis

5.1 Amount

  • No dividends for MPH!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

MPH.CA Fundamentals: All Metrics, Ratios and Statistics

MEDICURE INC

TSX-V:MPH (3/11/2026, 7:00:00 PM)

0.95

-0.02 (-2.06%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-19
Earnings (Next)04-27
Inst Owners23.1%
Inst Owner ChangeN/A
Ins Owners26.42%
Ins Owner ChangeN/A
Market Cap9.92M
Revenue(TTM)26.21M
Net Income(TTM)-3.43M
Analysts40
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.38
P/FCF 7.82
P/OCF 5.78
P/B 0.57
P/tB 2.18
EV/EBITDA N/A
EPS(TTM)-0.33
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.12
FCFY12.79%
OCF(TTM)0.16
OCFY17.31%
SpS2.51
BVpS1.66
TBVpS0.44
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -12.83%
ROE -19.81%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 47.67%
FCFM 4.84%
ROA(3y)-0.74%
ROA(5y)-4.98%
ROE(3y)-1.05%
ROE(5y)-8.57%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.73%
GM growth 5Y-1.35%
F-Score4
Asset Turnover0.98
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF 0.79
Debt/EBITDA N/A
Cap/Depr 17.23%
Cap/Sales 1.71%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.44
Quick Ratio 1
Altman-Z -2.26
F-Score4
WACC7.75%
ROIC/WACCN/A
Cap/Depr(3y)19.82%
Cap/Depr(5y)17.11%
Cap/Sales(3y)1.99%
Cap/Sales(5y)1.95%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-68.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-279.68%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)24.3%
Revenue growth 3Y0.25%
Revenue growth 5Y1.66%
Sales Q2Q%56.6%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y17.48%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-13.56%
FCF growth 3Y-41.4%
FCF growth 5YN/A
OCF growth 1Y4%
OCF growth 3Y-29.85%
OCF growth 5YN/A

MEDICURE INC / MPH.CA Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for MEDICURE INC?

ChartMill assigns a fundamental rating of 3 / 10 to MPH.CA.


What is the valuation status for MPH stock?

ChartMill assigns a valuation rating of 2 / 10 to MEDICURE INC (MPH.CA). This can be considered as Overvalued.


What is the profitability of MPH stock?

MEDICURE INC (MPH.CA) has a profitability rating of 3 / 10.